Cardiac structural, functional and energetic assessments during and after pregnancy in women with gestational diabetes mellitus, preeclampsia and healthy pregnancy.

Autor: Thirunavukarasu S; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom., Ansari F; Department of Fetal Medicine, Leeds General Infirmary, The Leeds Teaching Hospitals NHS Trust, LS1 3EX, United Kingdom., Kotha S; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom., Giannoudi M; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom., Procter H; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom., Cash L; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom., Chowdhary A; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom., Jex N; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom., Shiwani H; Cardiac Imaging Department, Barts Heart Centre St Bartholomew's Hospital, London, UK., Forbes K; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom., Valkovič L; University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR), RDM Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom; Department of Imaging Methods, Institute of Measurement Science, Slovak Academy of Sciences, Bratislava, Slovakia., Kellman P; National Heart, Lung, and Blood Institute, National Institutes of Health, DHHS, 10 Center Drive MSC-1061, Bethesda, MD, 20892, USA., Plein S; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom., Greenwood JP; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom; Baker Heart and Diabetes Institute, Melbourne, Australia; Monash University, Melbourne, Australia; University of Melbourne, Australia., Everett T; Department of Fetal Medicine, Leeds General Infirmary, The Leeds Teaching Hospitals NHS Trust, LS1 3EX, United Kingdom., Scott EM; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom., Levelt E; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom.

Publikováno v: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22.

Liraglutide Improves Myocardial Perfusion and Energetics and Exercise Tolerance in Patients With Type 2 Diabetes.

Autor: Chowdhary A; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Thirunavukarasu S; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Joseph T; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Jex N; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Kotha S; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Giannoudi M; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Procter H; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Cash L; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Akkaya S; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Broadbent D; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Xue H; National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA., Swoboda P; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Valkovič L; Centre for Clinical Magnetic Resonance Research (OCMR), RDM Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom; Institute of Measurement Science, Slovak Academy of Sciences, Bratislava, Slovakia., Kellman P; National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA., Plein S; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom., Rider OJ; Centre for Clinical Magnetic Resonance Research (OCMR), RDM Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom., Neubauer S; Centre for Clinical Magnetic Resonance Research (OCMR), RDM Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom., Greenwood JP; Baker Heart and Diabetes Institute, Melbourne, Australia; Monash University, Melbourne, Australia; University of Melbourne, Melbourne, Australia., Levelt E; University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom; Baker Heart and Diabetes Institute, Melbourne, Australia. Electronic address: e.levelt@leeds.ac.uk.

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Aug 06; Vol. 84 (6), pp. 540-557.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy.

Autor: Maron MS; Hypertrophic Cardiomyopathy Center, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA. Electronic address: martin.maron@lahey.org., Mahmod M; Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Abd Samat AH; Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Choudhury L; Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Massera D; Hypertrophic Cardiomyopathy Program, Leon H. Charney Division of Cardiology, NYU Langone Health, New York, New York, USA., Phelan DMJ; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA., Cresci S; Center for Cardiovascular Research, Washington University School of Medicine in St Louis, St Louis, Missouri, USA., Martinez MW; Division of Cardiology, Atlantic Health System, Morristown, New Jersey, USA., Masri A; Hypertrophic Cardiomyopathy Center, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA., Abraham TP; Division of Cardiology, University of California-San Francisco, San Francisco, California, USA., Adler E; Division of Cardiovascular Medicine, Department of Medicine, University of California-San Diego, La Jolla, California, USA., Wever-Pinzon O; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah and Salt Lake Veterans Affairs Medical Center, Salt Lake City, Utah, USA., Nagueh SF; Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA., Lewis GD; Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Chamberlin P; Imbria Pharmaceuticals, Boston, Massachusetts, USA., Patel J; Imbria Pharmaceuticals, Boston, Massachusetts, USA., Yavari A; Imbria Pharmaceuticals, Boston, Massachusetts, USA., Dehbi HM; Imbria Pharmaceuticals, Boston, Massachusetts, USA., Sarwar R; Imbria Pharmaceuticals, Boston, Massachusetts, USA., Raman B; Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Valkovič L; Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Neubauer S; Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Udelson JE; Division of Cardiology, Tufts Medical Center, Boston, Massachusetts, USA., Watkins H; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 May 28; Vol. 83 (21), pp. 2037-2048. Date of Electronic Publication: 2024 Apr 08.